Status:
ACTIVE_NOT_RECRUITING
Biomarkers and Event Patterns of Vascular Disease in Hemodialysis
Lead Sponsor:
Medical University of Graz
Collaborating Sponsors:
LKH Feldkirch
Elisabethinen Hospital
Conditions:
Vascular Disease
CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Eligibility:
All Genders
18-100 years
Brief Summary
Parathyroid hormone (PTH) remains the central biomarker to classify CKD-metabolic bone disease (CKD-MBD) in hemodialysis patients. While PTH-values are known to be associated with adverse outcomes, in...
Eligibility Criteria
Inclusion
- Stable hemodialysis \> 3 months duration
Exclusion
- Pregnancy
- Acute infections with antibiotic treatment
Key Trial Info
Start Date :
October 15 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2027
Estimated Enrollment :
475 Patients enrolled
Trial Details
Trial ID
NCT07170761
Start Date
October 15 2022
End Date
December 31 2027
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University Graz
Graz, Styria, Austria, 8036